| 2022-06-03 | Sale | Fate Therapeutics, Inc. FATE | 1,439 0.0014% | $22.81 | $32,824 | -19.37% | ||
| 2017-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 963 0.0011% | $43.14 | $41,544 | +24.02% | |
| 2017-02-03 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,500 0.0017% | $42.55 | $63,825 | +23.74% | |
| 2017-01-17 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,750 0.002% | $40.65 | $71,138 | +31.5% | |
| 2017-01-10 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,750 0.002% | $43.37 | $75,898 | +23.56% | |
| 2016-11-23 | Fate Therapeutics, Inc. FATE | director | 112,780 0.245% | $2.66 | $299,995 | +11.55% | ||
| 2016-02-03 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,500 0.0017% | $38.06 | $57,090 | +15.18% | |
| 2016-01-19 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,750 0.0021% | $46.69 | $81,708 | -0.89% | |
| 2016-01-11 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,750 0.002% | $44.25 | $77,438 | +2.78% | |
| 2015-10-16 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 25,000 0.0295% | $47.78 | $1.19M | +0.15% | |
| 2015-07-20 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 20,000 0.0244% | $55.00 | $1.1M | -11.04% | |
| 2015-07-13 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 20,000 0.0231% | $50.00 | $1M | -7.41% | |
| 2015-06-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 60,000 0.0699% | $45.08 | $2.7M | +3.67% | |
| 2015-03-20 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 40,000 0.0508% | $44.49 | $1.78M | +5.73% | |
| 2015-01-16 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 1,750 0.0021% | $30.81 | $53,918 | +45.6% | |
| 2015-01-12 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 3,500 0.0042% | $28.37 | $99,295 | +54.85% | |
| 2015-01-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 20,000 0.0135% | $14.92 | $298,400 | +65.94% | |
| 2014-12-19 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 20,000 0.0258% | $24.02 | $480,400 | +78.28% | |
| 2014-12-18 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 40,000 0.0519% | $23.60 | $944,000 | +82.59% | |
| 2014-12-10 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Financial Officer | 30,000 0.0288% | $16.02 | $480,700 | +98.77% |